ADMA BIOLOGICS, INC.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Total Revenue $10.5m $15.6m $17.0m $29.3m $42.2m $80.9m $154.1m $258.2m $426.5m $510.2m
Cost of Goods and Services Sold $6.4m $2.8m $8.8m $15.3m $22.0m $42.1m $118.8m $169.3m $206.9m $217.4m
Gross Profit (derived) $4.3m ($6.4m) ($25.2m) $14.1m ($19.1m) $1.2m $35.3m $88.9m $219.6m $292.8m
Operating Expenses $28.0m $62.1m $77.3m $70.8m $107.1m $59.5m $74.6m $67.3m $80.6m $101.3m
Operating Income (Loss) ($17.3m) ($39.3m) ($60.3m) ($41.4m) ($64.9m) ($58.4m) ($39.4m) $21.6m $139.0m $191.4m
Additional Financial Items
Amortization of Intangible Assets $0 $1.2m $845k $845k $715k $715k $715k $724k $388k $144k
Goodwill, Impairment Loss $0 $0 $0 $0 $0
Income (Loss) from Continuing Operations before Income Taxes, Domestic ($19.5m) $65.9m $28.2m $125.7m $182.7m
Interest Income, Other $50k $57k $195k $801k
Other Income $4k
Other Operating Income ($17.3m) $7.0m $0 ($41.4m) ($64.9m) ($58.4m) ($39.4m) $21.6m $139.0m $191.4m
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest ($19.5m) $65.9m $28.2m $125.7m $182.7m
Gain (Loss) on Derivative Instruments, Net, Pretax $0
Net Income (Loss) Attributable to Parent ($19.5m) ($43.8m) ($65.7m) ($48.3m) ($75.7m) ($71.6m) ($65.9m) ($28.2m) $197.7m $146.9m
Earnings Per Share, Basic ($0.88) ($0.51) ($0.33) ($0.13) $0.85 $0.62
Earnings Per Share, Diluted ($1.61) ($1.91) ($1.45) ($0.89) ($0.88) ($0.51) ($0.33) ($0.13) $0.81 $0.60
Weighted Average Number of Shares Outstanding, Basic 139.6m 197.9m 224.0m 233.1m 238.3m
Weighted Average Number of Shares Outstanding, Diluted 139.6m 197.9m 224.0m 243.3m 244.9m
Research and Development Expense $7.7m $6.2m $3.9m $2.3m $5.9m $3.6m $3.6m $3.3m $1.8m $4.8m
General and Administrative Expense $8.5m $18.1m $22.5m $25.9m $35.1m
Selling, General and Administrative Expense $35.1m $42.9m $52.5m $59.0m $74.1m $91.6m
Other Nonoperating Income (Expense) ($10k) ($127k) ($227k) ($129k) ($252k) ($634k) ($287k) ($193k) ($212k)
Interest Expense (non-operating) $13.9m $7.1m
Business Combination, Acquisition Related Costs $3.9m
Current Income Tax Expense (Benefit) $0 $0 $12.3m $24.7m
Interest Expense $2.2m $3.3m $5.5m $9.0m $12.0m $13.1m $19.3m $25.0m $13.9m $7.1m
Marketing and Advertising Expense $600k $800k $1.0m $1.1m $1.4m $2.2m $3.3m $2.7m $3.1m
Operating Lease, Expense $1.4m $2.1m $2.4m $2.4m $2.4m
Other Cost and Expense, Operating $5.4m $6.5m $7.8m $2.2m $4.2m $12.3m $17.8m $4.3m $4.2m $4.8m
Other Expenses $200k
Income Tax Expense (Benefit) $0 $0 $0 $0 $0 $0 $0 $0 ($72.0m) $35.7m